dc.date.accessioned2022-12-14T14:25:36Z
dc.date.accessioned2023-05-23T18:55:24Z
dc.date.available2022-12-14T14:25:36Z
dc.date.available2023-05-23T18:55:24Z
dc.date.created2022-12-14T14:25:36Z
dc.date.issued2022
dc.identifierhttps://hdl.handle.net/20.500.12866/12908
dc.identifierhttps://doi.org/10.17843/rpmesp.2022.393.10883
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6395417
dc.description.abstractKaposi’s sarcoma (KS) is the most frequent cancer in people living with HIV. Research on this condition is scarce in the region, therefore, this article aimed to describe the demographic, clinical and therapeutic characteristics of patients with HIV who developed KS at the Cayetano Heredia Hospital between 2000 and 2018. A total of 129 KS cases were identified, with a median age of 33 years, predominantly males with 92% (119/129), and mostly men who have sex with men (MSM). The median time from HIV diagnosis to KS diagnosis was five months, associated with a CD4 lymphocyte count of 64 cells/μL (IQR: 33-185) at KS diagnosis. Cutaneous involvement was the most common presentation; however, at least half also had the visceral form.
dc.languageeng
dc.publisherInstituto Nacional de Salud
dc.relationRevista Peruana de Medicina Experimental y Salud Publica
dc.relation1726-4642
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectLatin America
dc.subjectHIV
dc.subjectAIDS
dc.subjectKaposi’s Sarcoma
dc.titleKaposi's sarcoma in people living with HIV/AIDS in a public referral hospital in Peru
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución